POST Online Media Lite Edition


Synergy Pharma names SVP, drug development

Staff writer |
New York, USA - May 30, 2014, New York, USA - Synergy Pharmaceuticals Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced the appointment of Paul Eng as senior vice president, drug development.

Article continues below

Prior to joining Synergy, Dr. Eng was Director of Gastroenterology Clinical Development at Forest Laboratories, Inc., where he was chiefly responsible as study director for the successful pivotal phase 3 clinical trials that led to NDA and drug approval for treatment of CIC and IBS-C.


J&J Snack Foods appoints two to board
Rayont appoints Ilenna Copley as COO
Turning Point Therapeutics appoints Steve Sabus as CCO
Weyerhaeuser appoints David M. Wold as chief financial officer
Belk appoints Don Hendricks as interim CEO

What to read next

Verona Pharma CFO Biresh Roy steps down
Cardiome Pharma adds Robert James Meyer to board
Redx Pharma appoints Bernhard Kirschbaum as non-executive director